Separating microbes and cancers The role of microorganisms in causing and sustaining cancers has been in dispute for centuries. Through the lens of gut- and tumor-associated microbes, Sepich-Poore et al. review our current understanding of the microbiota in cancer,...

Micronoma, a San Diego, Calif.-based cancer detection biotech company that utilizes signals from the tumor-related microbiome to diagnose cancer at an early stage with liquid biopsy technology, closed a $3.5m convertible debt financing round. Read full story.

Read the article at CIO Applications

Read the full article on GenomeWeb.

San Diego-based Micronoma, a startup using microbiome analysis for early cancer detection, has appointed Magda Marquet as chairman of the firm’s board.

Microbiomics is taking a sharp turn. Until now, the field was limited to fecal transplants from healthy patients to those with gut conditions. The transplant is an awkward procedure that also creates regulatory and other challenges. Read More.

  NEW YORK – Following a successful $3 million seed funding round earlier this month, University of California, San Diego spinout Micronoma is commercializing a blood-based diagnostic assay that identifies a patient's organ microbiome signature to potentially...

Micronoma, an early cancer-detection biotech that seeks to develop and commercialize a minimally invasive, microbiome-based method, announced today that it has closed a $3 million seed financing round led by microbiome-focused investor, SymBiosis, LLC. Read More.

The road of drug development is rife with detours and disappointments but Seres Therapeutics showed this week that course corrections can work. Four years after its microbiome therapy failed in a mid-stage study, the company reported early positive data from a pivotal...

San Diego-based Micronoma, a startup working on early cancer detection, announced this morning that it has raised $3M in a seed financing round. The funding was led by SymBiosis, LLc. According to the company,

  A study suggests the potential for a noninvasive diagnostic that could detect tumors early and differentiate between disease types. Read More.

The story behind this paper begins with the loss of my grandmother to pancreatic cancer and the relentless pursuit to understand her disease. Projects along my educational path seemed like diversions (e.g. infectious disease genomics) but provided valuable skills to...